@article{dbb5d23279f84e339843ca6e724a4251,
title = "Comments on cochrane review on direct-acting antivirals for hepatitis C",
author = "Lok, {Anna S.} and Chung, {Raymond T.} and Vargas, {Hugo E.} and Kim, {Arthur Y.} and Susanna Naggie and Powderly, {William G.}",
note = "Funding Information: Copyright VC 2017 by the American Association for the Study of Liver Diseases. View this article online at wileyonlinelibrary.com. DOI 10.1002/hep.29366 Potential conflict of interest: Dr. Lok received grants from Bristol-Myers Squibb and Gilead. Dr. Chung received grants from Gilead, AbbVie, Janssen, Merck, and Bristol-Myers Squibb. Dr. Vargas received grants from AbbVie, Gilead, and Merck. Dr. Naggie received grants from Gilead, AbbVie, and Merck. Dr. Powderly consults and received grants from Merck. He consults for Gilead.",
year = "2017",
month = oct,
doi = "10.1002/hep.29366",
language = "English (US)",
volume = "66",
pages = "1016--1019",
journal = "Hepatology",
issn = "0270-9139",
publisher = "John Wiley and Sons Ltd",
number = "4",
}